STAT
NOVEMBER 6, 2024
The executive in charge of AstraZeneca operations in China is under detention by Chinese authorities who are investigating employees there, the company said. The disclosure comes after AstraZeneca last week acknowledged that Leon Wang, an executive vice president who also oversees international operations for the drugmaker, was being investigated along with a “small number” of employees.
Pharmacy Times
NOVEMBER 6, 2024
Jeff Boyer, PharmD, BCPS, discusses his role in opioid stewardship at the Southern Arizona VA Healthcare System, highlighting his work in pain management coordination, interdisciplinary collaboration, patient and provider education, and data-driven strategies to support safe opioid use and address the opioid crisis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 6, 2024
Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a past COVID-19 vaccine supply deal. The Maryland biotech has agreed to pay $123.8 million to end a COVID vaccine supply pact with the U.K.
Pharmacy Times
NOVEMBER 6, 2024
The authors believe that improvements can be made to overlook the motherhood penalty and its associated pay gaps as well as changes to address workforce burnout.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 6, 2024
Streamline your pharmacy operations with centralized fulfillment. Discover how automation and advanced software can improve patient care, reduce operational errors, and create a better work environment for pharmacists. Download our whitepaper to learn how centralized fulfillment can address rising prescription volumes and staffing shortages. Request a consultation today to explore the best solution for your pharmacy.
Pharmacy Times
NOVEMBER 6, 2024
Patients with low-grade intermediate-risk non-muscle-invasive bladder cancer who achieved a complete response rate after 3 months of UGN-102 treatment had an 82.3% duration of response at 12 months.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 6, 2024
For up to 6 years, cognitive remediation and transcranial direct current stimulation slowed cognitive decline associated with major depressive disorder in remission and mild cognitive impairment.
pharmaphorum
NOVEMBER 6, 2024
Two players in medical extended reality (XR) – XRHealth and NeuroReality – have come together in a quest to build the biggest company in the sector.Boston, US-based XRHealth is leading the deal, acquiring NeuroReality of the Netherlands for an undisclosed sum, combining their products and expertise in the use of XR and virtual reality software for healthcare applications.
Pharmacy Times
NOVEMBER 6, 2024
Clesrovimab reduced RSV-associated hospitalizations and RSV-associated lower respiratory infection hospitalizations by more than 84% and 90% in preterm and full-term infants, respectively.
STAT
NOVEMBER 6, 2024
Want to self-prescribe a prescription drug? No problem! Some of the largest pharmaceutical companies in the U.S. are piloting websites that essentially sell their drugs directly to consumers. This unprecedented move launches a new dystopic era: pharmaceutical companies as health care provider, no pesky physician middlemen needed. It’s what the pharmaceutical industry has always wanted: They have long viewed physicians as inconvenient barriers between the company and their customers.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 6, 2024
Increased bone marrow adiposity is associated with progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma.
STAT
NOVEMBER 6, 2024
Massachusetts voters on Tuesday rejected Question 4, the ballot measure that proposed decriminalizing the use of psychedelic substances for people older than 21 and allowing people to grow the hallucinogens at home. The AP projected the result in the early morning hours of Wednesday. The initiative proposed to decriminalize the use of five psychedelic compounds, most notably psilocybin , or so-called magic mushrooms, which can dramatically affect a person’s perceptions and thinking.
Drug Topics
NOVEMBER 6, 2024
Checkout some of the most important sessions and video interviews from the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo.
STAT
NOVEMBER 6, 2024
LONDON — Sales of Novo Nordisk’s obesity drug Wegovy jumped in the third quarter, the company said Wednesday as it reported quarterly profits that were in line with analyst expectations. Novo’s third quarter performance will be seen as a win for the company, particularly after Eli Lilly — its rival in the booming obesity drug market — reported earnings last week that fell below forecasts.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The FDA Law Blog
NOVEMBER 6, 2024
By Sara W. Koblitz — The fight between Jazz, Avadel, and FDA over narcolepsy drug sodium oxybate has been a long and arduous one. Starting in 2022 with a patent certification requirement, both Jazz and Avadel have sued FDA over this drug, with Jazz most recently bringing suit challenging FDA’s decision that Avadel’s Lumryz (sodium oxybate) is clinically superior to Jazz’s Xywav (sodium oxybate) in 2023.
European Pharmaceutical Review
NOVEMBER 6, 2024
Dupixent (dupilumab) has been approved by the European Medicines Agency (EMA) as the first treatment for young children with eosinophilic esophagitis in the EU. This authorisation is based on Phase III data which found that 68 percent of children aged one to 11 years given Dupixent (dupilumab) achieved histological disease remission at 16 weeks. This result was maintained for up to one year.
Pharmaceutical Technology
NOVEMBER 6, 2024
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts by the US Federal Reserve in September 2024.
Pharmacy Times
NOVEMBER 6, 2024
Brian Anderson, PharmD, RPh provides important considerations for pharmacists regarding patient use of benzodiazepines.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
NOVEMBER 6, 2024
CVS Health announced two key leadership appointments as it continues the push to improve its financial performance. | CVS Health announced two key leadership appointments as it continues the push to improve its financial performance.
STAT
NOVEMBER 6, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. Regardless of elections, we generally see the proverbial glass as half full. For those of you who worry the sky is falling, we will pass along something learned on Wall Street: “Sell sky.” After all, we have made it this far, so we are determined to hang on for another couple of days.
Drug Topics
NOVEMBER 6, 2024
Researchers compared the issue of drug shortages and supply chain challenges between the US and Canada.
pharmaphorum
NOVEMBER 6, 2024
Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago.
STAT
NOVEMBER 6, 2024
No matter who wins the 2024 presidential race, one thing is clear: Political anxiety and division will remain high for the foreseeable future. So just before Election Day, I spoke with Kevin Smith, a professor of political science at the University of Nebraska who studies the intersection of political attitudes, biology, and evolution. In 2019, he and colleagues published a study that found almost 40% of Americans reported experiencing stress over politics, 11.5% thought their physical hea
Drug Topics
NOVEMBER 6, 2024
Ruth Carrico, PhD, DNP, APRN, sat down with Drug Topics to discuss the importance of COVID-19 and influenza vaccination.
STAT
NOVEMBER 6, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, major news this morning, so let’s get straight to it.
Fierce Healthcare
NOVEMBER 6, 2024
The U.S. Supreme Court heard oral arguments Monday in a case centered on Congress’ formula for calculating disproportionate share hospital payments. | The U.S. Supreme Court heard oral arguments Monday in a case centered on Congress’ formula for calculating disproportionate share hospital payments.
pharmaphorum
NOVEMBER 6, 2024
HCG’s drive to transform is motivated by industry-leading perspective on the emerging trend of “impact”, and recognition that understanding that the impact of medical communications efforts is more critical than ever.
Fierce Pharma
NOVEMBER 6, 2024
Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report kdunleavy Wed, 11/06/2024 - 09:23
pharmaphorum
NOVEMBER 6, 2024
New results with Alligator's CD40 agonist mitazalimab show it nearly doubled survival in pancreatic cancer, ahead of phase 3 trial next year.
Drug Topics
NOVEMBER 6, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how insulin icodec differs from existing daily basal insulins and key things pharmacists need to know about the medication.
Outsourcing Pharma
NOVEMBER 6, 2024
As clinical trials evolve, electronic Clinical Outcome Assessments (eCOA) remain central to data quality but often lag in adoption due to complex setup and deployment challenges.
Fierce Pharma
NOVEMBER 6, 2024
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its GLP-1 stalwarts Ozempic and Wegovy is more of a mixed bag. | Among Novo’s semaglutide-based drugs, diabetes blockbuster Ozempic fell short of analysts' expectations during the third quarter while weight-loss med Wegovy came above a consensus estimate.
Pharmacy Times
NOVEMBER 6, 2024
Known to be a leading cause of mortality worldwide, cigarette smoke exposure can make the respiratory tract more susceptible to pneumococcal infection.
Expert insights. Personalized for you.
145 
Let's personalize your content